- Home
- RNXT vs MDAI Comparison
RNXT vs MDAI Comparison
Compare RNXT & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- MDAI
- Stock Information
- Founded
- RNXT 2012
- MDAI 2013
- Country
- RNXT United States
- MDAI United States
- Employees
- RNXT N/A
- MDAI N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- MDAI Medical/Dental Instruments
- Sector
- RNXT Health Care
- MDAI Health Care
- Exchange
- RNXT Nasdaq
- MDAI Nasdaq
- Market Cap
- RNXT 30.0M
- MDAI 28.3M
- IPO Year
- RNXT 2021
- MDAI N/A
- Fundamental
- Price
- RNXT $1.27
- MDAI $1.78
- Analyst Decision
- RNXT Strong Buy
- MDAI Strong Buy
- Analyst Count
- RNXT 2
- MDAI 3
- Target Price
- RNXT $6.50
- MDAI $4.50
- AVG Volume (30 Days)
- RNXT 118.6K
- MDAI 5.6M
- Earning Date
- RNXT 11-13-2024
- MDAI 11-06-2024
- Dividend Yield
- RNXT N/A
- MDAI N/A
- EPS Growth
- RNXT N/A
- MDAI N/A
- EPS
- RNXT N/A
- MDAI N/A
- Revenue
- RNXT N/A
- MDAI $27,264,000.00
- Revenue This Year
- RNXT N/A
- MDAI $62.68
- Revenue Next Year
- RNXT N/A
- MDAI N/A
- P/E Ratio
- RNXT N/A
- MDAI N/A
- Revenue Growth
- RNXT N/A
- MDAI 44.52
- 52 Week Low
- RNXT $0.68
- MDAI $0.82
- 52 Week High
- RNXT $2.35
- MDAI $3.72
- Technical
- Relative Strength Index (RSI)
- RNXT 52.77
- MDAI 50.77
- Support Level
- RNXT $1.21
- MDAI $1.78
- Resistance Level
- RNXT $1.55
- MDAI $2.06
- Average True Range (ATR)
- RNXT 0.12
- MDAI 0.36
- MACD
- RNXT -0.02
- MDAI -0.03
- Stochastic Oscillator
- RNXT 32.20
- MDAI 27.10
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.